Study Stopped
study withdrawn, no participant enrolled, change in the study design planned
A CCTA Guided Management Strategy Versus a Standard of Care Strategy in Type 2 NSTEMI
Randomized Control Trial of Outcomes Comparing a Coronary Computed Tomography Angiography (CCTA) Guided Management Strategy Versus a Standard of Care Strategy in Type 2 Non-ST-elevation MI
1 other identifier
observational
N/A
1 country
1
Brief Summary
This study design is a prospective randomized control trial to compare outcomes between the utilization of coronary computed tomography angiography (CCTA) vs conservative treatment in type 2 NSTEMI. The targeted population is expectedly heterogeneous and inpatient setting who are admitted and diagnosed with type 2 NSTEMI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 19, 2024
CompletedFirst Posted
Study publicly available on registry
April 24, 2024
CompletedStudy Start
First participant enrolled
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedMarch 17, 2025
May 1, 2024
8 months
April 19, 2024
March 13, 2025
Conditions
Outcome Measures
Primary Outcomes (6)
MACE
Time to the first major adverse cardiac event (MACE) at 3 years between 2 groups. Unit: no unit (yes/no)
anytime within 3 years
Cardiovascular (CV) mortality
Cardiovascular (CV) mortality Unit: no unit (yes/no)
anytime within 3 years
Nonfatal MI, stroke
Nonfatal MI, stroke Unit: no unit (yes or no)
anytime within 3 years
Hospitalization for unstable angina
Hospitalization for unstable angina Unit: no unit (yes or no)
anytime within 3 years
Hospitalization for heart failure
Hospitalization for heart failure Unit: no unit (yes or no)
anytime within 3 years
Unplanned revascularization
Unplanned revascularization Unit: no unit (yes or no)
anytime within 3 years
Secondary Outcomes (5)
All-cause mortality
anytime within 3 years
In-hospital and 90-day costs
anytime within 90 days
Patient quality of life at 90 days
anytime within 90 days
Diagnostic certainty scores
anytime within 3 years
Individual components of the primary endpoint
anytime within 3 years
Study Arms (2)
CCTA Group
CT group will undergo CCTA to evaluate for coronary artery disease to early address underlying CAD and then care will be directed based on the findings of that CT scan.
No CCTA Group
Group 2 will not undergo CCTA and will be managed at the discretion of the primary team using the standard of care pathway comprising of either conservative medical management, stress testing, or invasive evaluation with coronary angiography in the catheterization laboratory.
Interventions
• CCTA will be performed per the standard clinical protocol using a Cannon Aquilion ONE scanner with 16 cm z-axis coverage at 0.5 mm resolution, low contrast, and reduced radiation dose requirements.
Eligibility Criteria
Hospitalized patients diagnosed with type 2 NSTEMI.
You may qualify if:
- Inpatient with type 2 NSTEMI
- Aged 18-70 years old
- At the University of Louisville and Jewish hospitals
You may not qualify if:
- History of severe or anaphylactic reaction to iodinated contrast
- Inability to cooperate with scan protocols
- Hemodynamic instability
- Decompensated heart failure
- Acute myocardial infarction
- Renal impairment with GFR \< 30
- Pregnancy
- Inability to tolerate heart rate-slowing medications or nitroglycerin
- Recent phosphodiesterase inhibitor use
- Severe aortic stenosis
- Bronchospastic disease
- Patient's weight and height
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Louisville School of Medicine, Division of Cardiovascular Diseases
Louisville, Kentucky, 40202, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Dinesh Kalra, MD
University of Louisville School of Medicine
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 19, 2024
First Posted
April 24, 2024
Study Start
May 1, 2024
Primary Completion
January 1, 2025
Study Completion
January 1, 2025
Last Updated
March 17, 2025
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share